Market Cap 7.59M
Revenue (ttm) 23.34M
Net Income (ttm) -101.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -433.89%
Debt to Equity Ratio -1.41
Volume 23,971
Avg Vol 272,611
Day's Range N/A - N/A
Shares Out 2.51M
Stochastic %K 37%
Beta -1.47
Analysts Strong Buy
Price Target $18.74

Company Profile

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierg...

Industry: Medical Distribution
Sector: Healthcare
Phone: 844 203 6092
Address:
3000 Bayport Drive, Suite 950, Tampa, United States
Latest News on MEDS
Wellgistics Health Provides Mid-Year 2026 Corporate Outlook

Jun 1, 2026, 7:40 AM EDT - 2 months ago

Wellgistics Health Provides Mid-Year 2026 Corporate Outlook


Wellgistics Health Completes Reverse Split

May 26, 2026, 8:00 AM EDT - 2 months ago

Wellgistics Health Completes Reverse Split


Wellgistics Health Releases Letter to Our Shareholders

May 21, 2026, 9:35 AM EDT - 2 months ago

Wellgistics Health Releases Letter to Our Shareholders


Wellgistics Health Announces Reverse Stock Split

May 20, 2026, 6:00 PM EDT - 2 months ago

Wellgistics Health Announces Reverse Stock Split


Wellgistics Health Provides 2026 Corporate Outlook

Jan 7, 2026, 7:40 AM EST - 7 months ago

Wellgistics Health Provides 2026 Corporate Outlook


Wellgistics Health Enters into LOI to Acquire Kare Rx Hub

Nov 4, 2025, 6:00 AM EST - 9 months ago

Wellgistics Health Enters into LOI to Acquire Kare Rx Hub


Wellgistics Health Announces Pricing of $5 Million Public Offering

Sep 25, 2025, 8:01 PM EDT - 11 months ago

Wellgistics Health Announces Pricing of $5 Million Public Offering